ARTS WAY director granted 1,000 ARTW shares

Buffamante Thomas E reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/02/2026 - 09:00 AM EST

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Buffamante Thomas E reported acquisition or exercise transactions in this Form 4 filing.

ARTS WAY MANUFACTURING CO INC director Thomas E. Buffamante received a grant of 1,000 shares of common stock as part of the company’s director compensation plan. These fully vested restricted shares increased his directly held stake to 60,000 common shares following the award.

Insider Trade Summary

Grant/Award: 1,000 shares

Grant/Award 1 txn

Insider Buffamante Thomas E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 60,000 shares (Direct)

Footnotes (1)

F1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARTW director Thomas E. Buffamante report on this Form 4?

Thomas E. Buffamante reported acquiring 1,000 shares of ARTS WAY MANUFACTURING CO INC common stock. The filing states this was a fully vested restricted stock grant made under the company’s director compensation plan, rather than an open-market purchase or sale transaction.

How many ARTW shares does Thomas E. Buffamante own after this reported grant?

After the grant, Thomas E. Buffamante directly holds 60,000 shares of ARTS WAY MANUFACTURING CO INC common stock. The Form 4 indicates this figure as the total common shares owned following the award of 1,000 fully vested restricted shares under the director compensation plan.

Was the ARTW Form 4 transaction a stock purchase or a restricted stock grant?

The ARTW Form 4 reflects a restricted stock grant, not a market purchase. A footnote explains the 1,000 shares represent fully vested restricted stock issued pursuant to the director compensation plan, with a reported per-share transaction price of $0.0000 on the form.

What is the transaction code used in the ARTW Form 4 for this award?

The Form 4 uses transaction code “A” for this award to the ARTW director. The filing describes this code as a grant, award, or other acquisition, consistent with the 1,000-share fully vested restricted stock grant under the company’s director compensation plan.

Does the ARTW Form 4 indicate direct or indirect ownership of the reported shares?

The ARTW Form 4 shows the 1,000 granted shares as directly owned by the reporting person. The ownership type is listed as direct with code “D,” and there is no footnote indicating that the shares are held through a separate entity or trust structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buffamante Thomas E

(Last)

(First)

(Middle)

5556 HIGHWAY 9

(Street)

ARMSTRONG

50514

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTS WAY MANUFACTURING CO INC [ ARTW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/28/2026		A		1,000⁽¹⁾	A	$0	60,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents fully-vested restricted stock granted pursuant to the director compensation plan.

	/s/ Michael W. Woods as Attorney-in-Fact for Thomas E. Buffamante	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR